retatrutide clinical trials results trial information phase approval: FDA status, results, and when it could be available Do not obsess over Retatrutide. – New Retatrutide Phase 3 Trial – retatrutide clinical trial stage New

Check with your insurance provider for coverage details

Laser Skin Resurfacing: Smooths skin tone and improves surface texture Medical-Grade Skincare: Maintains skin health and improves elasticity over time These treatments can be used on their own or in combination with surgery for long-term aesthetic maintenance

Medical and Cosmetic Procedures for Skin Lightening Skin-lightening treatments can go beyond creams and include medical or cosmetic procedures

After 24 weeks of treatment: people taking Farxiga 5 mg had their fasting blood sugar* levels decreased by 24.1 mg/dL and their hemoglobin A1c (A1C) level was lowered by 0.8%, on average people taking Farxiga 10 mg had their fasting blood sugar levels decreased by 28.8 mg/dL and their A1C level lowered by 0.9%, on average people taking the placebo had their fasting blood sugar levels decreased by 4.1 mg/dL and their A1C level lowered by 0.2%, on average About 44% to 51% of people in this study who took Farxiga for 24 weeks reached their goal A1C of less than 7%

iScience 25 , 104870 (2022)

Everything You Need to Succeed All in One Place Your program includes access to every resource you need